BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23114115)

  • 1. Anaemia in HIV-infected children: severity, types and effect on response to HAART.
    Nyesigire Ruhinda E; Bajunirwe F; Kiwanuka J
    BMC Pediatr; 2012 Oct; 12():170. PubMed ID: 23114115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
    J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
    Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
    HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa.
    Eley BS; Sive AA; Shuttleworth M; Hussey GD
    BMC Infect Dis; 2002; 2():3. PubMed ID: 11866864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
    Gedefaw L; Yemane T; Sahlemariam Z; Yilma D
    PLoS One; 2013; 8(8):e72202. PubMed ID: 23977253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
    Okechukwu AA; Gambo D; Okechukwu IO
    Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
    Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
    Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda.
    Castelnuovo B; Mubiru F; Kiragga AN; Musomba R; Mbabazi O; Gonza P; Kambugu A; Ratanshi RP
    BMJ Open; 2018 Feb; 8(2):e015490. PubMed ID: 29467129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.
    Gunda DW; Kilonzo SB; Mpondo BC
    Pan Afr Med J; 2016; 23():26. PubMed ID: 27200131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.
    Owiredu WK; Quaye L; Amidu N; Addai-Mensah O
    Afr Health Sci; 2011 Mar; 11(1):2-15. PubMed ID: 21572851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
    Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
    BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
    Rougemont M; Nchotu Ngang P; Stoll B; Delhumeau C; Hill A; Ciaffi L; Bonnet F; Menga G; Fampou JC; Calmy A
    HIV Med; 2016 Mar; 17(3):206-15. PubMed ID: 26354678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.
    Bunupuradah T; Kariminia A; Chan KC; Ramautarsing R; Huy BV; Han N; Nallusamy R; Hansudewechakul R; Saphonn V; Sirisanthana V; Chokephaibulkit K; Kurniati N; Kumarasamy N; Yusoff NK; Razali K; Fong SM; Sohn AH; Lumbiganon P;
    Int J Infect Dis; 2013 Oct; 17(10):e806-10. PubMed ID: 23764352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
    Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
    Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth.
    Musoke PM; Barlow-Mosha L; Bagenda D; Mudiope P; Mubiru M; Ajuna P; Tumwine JK; Fowler MG
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):560-8. PubMed ID: 19950430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological Changes among HIV-Positive Persons on Antiretroviral Therapy at a Tertiary Hospital in Ghana.
    Obiri-Yeboah D; Charwudzi A; Baidoo IK; Botchway ET; Addo SA; Nsiah P; Ekem I
    West Afr J Med; 2020; 37(1):40-47. PubMed ID: 32030710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.